跳至主要内容
临床试验/jRCT1062210071
jRCT1062210071招募中不适用

A prospective randomized controlled trial of comparing 22 and 19G needles for tissue sampling with EUS-FNB for Cancer Gene Panel Test in solid pancreatic masses

未提供0 个研究点目标入组 44 人开始时间: 2022年2月4日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
44
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Crossover Assignment
主要目的
Diagnostic Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
20age old over 至 No limit(—)
性别
All

入选标准

  • Patients with solid pancreatic mass planned for Cancer Gene Panel Testing using EUS-FNB samples

排除标准

  • Performance status 3-4
  • Bleeding tendency or platelet count less than 50000/mm2
  • Taking two or more anti-thrombotic drugs
  • Difficult to perform EUS-FNB with safe due to interval vessels
  • Patients who could not obtain suitable informed consent
  • Patients judged by the reseach doctors as inappropriate subjects

结局指标

主要结局

-

Collection rate of adequate tissue sampling for Cancer Gene Panel Test

次要结局

  • Pathological evaluation of poorly enhanced area in tumor with CE-EUS

研究者

发起方
未提供

相似试验